This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2021 Jan;32(1-2):21-30.

doi: 10.1089/hum.2020.252. Epub 2020 Oct 30.

Bringing Gene Therapies for HIV Disease to Resource-Limited Parts of the World

Joseph M McCune¹, Emily H Turner¹, Adam Jiang¹, Brian P Doehle¹

Affiliations

PMID: 32998595
PMCID: PMC10112459
DOI: 10.1089/hum.2020.252

Bringing Gene Therapies for HIV Disease to Resource-Limited Parts of the World

Joseph M McCune et al. Hum Gene Ther. 2021 Jan.

. 2021 Jan;32(1-2):21-30.

doi: 10.1089/hum.2020.252. Epub 2020 Oct 30.

Authors

Joseph M McCune¹, Emily H Turner¹, Adam Jiang¹, Brian P Doehle¹

Affiliation

¹ HIV Frontiers, Global Health Innovative Technology Solutions, Bill & Melinda Gates Foundation, Seattle, Washington, USA.

PMID: 32998595
PMCID: PMC10112459
DOI: 10.1089/hum.2020.252

No abstract available

PubMed Disclaimer

Conflict of interest statement

No competing financial interests exist.

Figures

Figure 1. — Figure 1.
The vision for the HIV Frontiers Program.

Figure 2. — Figure 2.
The key elements of the HIV Frontiers Program.

Figure 3. — Figure 3.
Critical considerations in the discovery, development, and clinical application of therapies targeting and editing long-lived cells in vivo.

See this image and copyright information in PMC

Similar articles

Affordable HIV and sickle cell disease gene therapies.
Mullard A. Mullard A. Nat Rev Drug Discov. 2019 Nov;18(12):895. doi: 10.1038/d41573-019-00189-3. Nat Rev Drug Discov. 2019. PMID: 31780850 No abstract available.
Genetic therapies for HIV infections: promise for the future.
Pomerantz RJ, Trono D. Pomerantz RJ, et al. AIDS. 1995 Sep;9(9):985-93. doi: 10.1097/00002030-199509000-00002. AIDS. 1995. PMID: 8527094 Review. No abstract available.
[This is how the "gene scissors" function against HIV].
Oberhofer E. Oberhofer E. MMW Fortschr Med. 2016 Jun 9;158 Suppl 1:10. doi: 10.1007/s15006-016-8315-9. MMW Fortschr Med. 2016. PMID: 27259889 German. No abstract available.
Gene therapy for HIV-1 infection.
Kohn DB, Sarver N. Kohn DB, et al. Adv Exp Med Biol. 1996;394:421-8. doi: 10.1007/978-1-4757-9209-6_39. Adv Exp Med Biol. 1996. PMID: 8815708 Review. No abstract available.
Prospects for the therapeutic application of lentivirus-based gene therapy to HIV-1 infection.
Yamamoto T, Tsunetsugu-Yokota Y. Yamamoto T, et al. Curr Gene Ther. 2008 Feb;8(1):1-8. doi: 10.2174/156652308783688536. Curr Gene Ther. 2008. PMID: 18336245 Review.

See all similar articles

Cited by

Collaborative science to advance gene therapies in resource-limited parts of the world.
McCune JM, Stevenson SC, Doehle BP, Trenor CC 3rd, Turner EH, Spector JM. McCune JM, et al. Mol Ther. 2021 Nov 3;29(11):3101-3102. doi: 10.1016/j.ymthe.2021.05.024. Epub 2021 Aug 30. Mol Ther. 2021. PMID: 34464598 Free PMC article. No abstract available.
Ethical and practical considerations for cell and gene therapy toward an HIV cure: findings from a qualitative in-depth interview study in the United States.
Dubé K, Kanazawa J, Patel H, Louella M, Sylla L, Sheehy J, Dee L, Taylor J, Adair J, Anthony-Gonda K, Dropulić B, Sauceda JA, Peluso MJ, Deeks SG, Simoni J. Dubé K, et al. BMC Med Ethics. 2022 Apr 9;23(1):39. doi: 10.1186/s12910-022-00780-1. BMC Med Ethics. 2022. PMID: 35397551 Free PMC article.
The promise of a "cure" for HIV: implications for the future of PEPFAR-supported HIV programmes.
Raizes E, Blandford J, McCune JM, Dybul M. Raizes E, et al. J Int AIDS Soc. 2024 Jan;27(1):e26206. doi: 10.1002/jia2.26206. J Int AIDS Soc. 2024. PMID: 38193636 Free PMC article. No abstract available.
The long-term impact and value of curative therapy for HIV: a modelling analysis.
Guzauskas GF, Hallett TB. Guzauskas GF, et al. J Int AIDS Soc. 2023 Sep;26(9):e26170. doi: 10.1002/jia2.26170. J Int AIDS Soc. 2023. PMID: 37749063 Free PMC article.
Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?
Harper J, Betts MR, Lichterfeld M, Müller-Trutwin M, Margolis D, Bar KJ, Li JZ, McCune JM, Lewin SR, Kulpa D, Diallo DD, Lederman MM, Paiardini M. Harper J, et al. Pathog Immun. 2024 Mar 1;8(2):115-157. doi: 10.20411/pai.v8i2.665. eCollection 2023. Pathog Immun. 2024. PMID: 38455668 Free PMC article.

References

1. United Nations Joint Programme on HIV/AIDS (UNAIDS). 2018. The youth bulge and HIV. https://www.unaids.org/sites/default/files/media_asset/the-youth-bulge-a.... (last accessed September 22, 2020).
1. Hutter G, Nowak D, Mossner M, et al. . Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 2009;360:692–698. - PubMed
1. Gupta RK, Abdul-Jawad S, McCoy LE, et al. . HIV-1 remission following CCR5Delta32/Delta32 haematopoietic stem-cell transplantation. Nature 2019;568:244–248. - PMC - PubMed
1. Collins DR, Gaiha GD, Walker BD. CD8(+) T cells in HIV control, cure and prevention. Nat Rev Immunol 2020;20:471–482. - PMC - PubMed
1. Casado C, Galvez C, Pernas M, et al. . Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure. Sci Rep 2020;10:1902. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information